세계의 골내 주입 기기 시장 규모, 점유율 및 동향 분석 보고서 - 장치 유형별, 최종 사용자별, 지역별 전망 및 예측(2024-2031년)
Global Intraosseous Infusion Devices Market Size, Share & Trends Analysis Report By Devices Type (Manual IO Needles, Battery Powered Driver and Impact Driven Devices), By End User, By Regional Outlook and Forecast, 2024 - 2031
상품코드:1473130
리서치사:KBV Research
발행일:2024년 04월
페이지 정보:영문 164 Pages
라이선스 & 가격 (부가세 별도)
한글목차
골내 주입 기기 시장 규모는 예측 기간 동안 5.9%의 연평균 복합 성장률(CAGR)로 성장하여 2031년까지 14억 달러에 달할 것으로 예상됩니다.
또한, 코로나19 팬데믹은 의료 시스템에 전례 없는 부담을 안겨주었고, 이러한 장비와 같은 응급 의료 장비에 대한 수요가 급증했습니다. 또한, 코로나19 팬데믹은 의료 시스템이 전통적인 병원 환경 밖에서 코로나19 환자를 관리해야 하는 과제에 적응하면서 병원 전 진료 및 야외 진료로의 전환을 촉진했습니다. 이러한 장비는 고급 의료 시설에 대한 접근이 제한될 수 있는 지역 사회 환경, 야전 병원, 임시 치료 센터, 집단 예방 접종 현장에서 최전선에서 치료를 제공하는 응급 의료 서비스(EMS) 요원, 군 의료진, 구급대원에게 필수적인 도구가 되었습니다. 따라서 코로나19 팬데믹은 시장에 긍정적인 영향을 미쳤습니다.
그러나, 이러한 장비의 조달에 필요한 초기 투자비용이 높을 수 있으며, 이는 예산이 부족한 의료기관의 도입 장벽으로 작용할 수 있습니다. 또한 초기 조달 및 교육 외에도 지속적인 유지 보수 및 소모품 교체는 이러한 장비와 관련된 정기적 인 비용입니다. 따라서 이러한 측면은 시장 침체로 이어질 수 있습니다.
목차
제1장 시장 범위와 조사 방법
시장의 정의
목적
시장 범위
세분화
조사 방법
제2장 시장 요람
제3장 시장 개요
서론
개요
시장 구성과 시나리오
시장에 영향을 미치는 주요 요인
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
시장이 해결해야 할 과제
Porter의 Five Forces 분석
제4장 세계 시장 : 장비 유형별
세계의 수동 IO 바늘 시장 : 지역별
세계의 배터리 구동형 드라이버 시장 : 지역별
세계의 임팩트 구동형 장비 시장 : 지역별
제5장 세계 시장 : 최종사용자별
세계의 병원 및 클리닉 시장 : 지역별
세계의 외래수술센터(ASC) 시장 : 지역별
세계의 기타 시장 : 지역별
제6장 세계 시장 : 지역별
북미
북미 시장 : 국가별
미국
캐나다
멕시코
기타 북미
유럽
유럽 시장 : 국가별
독일
영국
프랑스
러시아
스페인
이탈리아
기타 유럽
아시아태평양
아시아태평양 시장 : 국가별
중국
일본
인도
한국
호주
말레이시아
기타 아시아태평양
라틴아메리카/중동 및 아프리카
라틴아메리카/중동 및 아프리카 시장 : 국가별
브라질
아르헨티나
아랍에미리트(UAE)
사우디아라비아
남아프리카공화국
나이지리아
기타 라틴아메리카/중동 및 아프리카
제7장 기업 개요
Aero Healthcare AU Pty Ltd
The Seaberg Company Inc(SAM Medical)
Medax Srl
PAVmed Inc
Teleflex Incorporated
Becton, Dickinson, and Company
Biopsybell SR.L
Cook Medical, Inc(Cook Group)
Argon Medical Devices, Inc(Shandong Weigao Group Medical Polymer Company Limited)
제8장 골내 주입 기기 시장을 위한 성공 필수 조건
LSH
영문 목차
영문목차
The Global Intraosseous Infusion Devices Market size is expected to reach $1.4 billion by 2031, rising at a market growth of 5.9% CAGR during the forecast period.
Healthcare systems in Europe prioritize patient safety, quality of care, and technological innovation. Thus, there is growing recognition of the importance of intraosseous access as a critical tool for rapid vascular access in emergency and critical care settings. Consequently, the Europe region would acquire nearly 30% of the total market share by 2031. Also, Europe boasts a well-developed healthcare infrastructure characterized by advanced medical facilities, robust regulatory frameworks, and high standards of patient care.
In moments of medical crisis, time is of the essence. These devices circumvent delays associated with conventional intravenous access, ensuring healthcare practitioners can promptly administer crucial medications and fluids to stabilize patients. Moreover, the increasing prevalence of medical emergencies underscores the importance of robust emergency response protocols. These devices play a pivotal role in these protocols, providing healthcare teams with a versatile and effective means of vascular access in diverse clinical settings, including pre-hospital environments, emergency departments, and critical care units. Thus, these factors will assist in the growth of the market. Additionally, the utilization of these devices extends beyond traditional emergency settings, permeating critical care units, military operations, and ambulatory care settings. This diversification of usage underscores the versatility of these devices in delivering a spectrum of essential treatments, including medications, fluids, and blood products, across varied healthcare landscapes. Moreover, the rugged and unpredictable nature of military operations necessitates medical interventions that are adaptable and resilient. These devices have emerged as indispensable assets in military healthcare settings, enabling frontline medics to initiate life-saving treatments swiftly and effectively, even in austere environments or under combat conditions. Hence, these aspects will pose lucrative growth prospects for the market.
Moreover, The COVID-19 pandemic placed an unparalleled burden on healthcare systems, resulting in a surge in the need for emergency medical apparatus, such as these devices. Moreover, the pandemic prompted a shift towards pre-hospital and field medicine as healthcare systems adapt to the challenges of managing COVID-19 patients outside traditional hospital settings. These devices became essential tools for emergency medical services (EMS) personnel, military medics, and first responders providing frontline care in community settings, field hospitals, makeshift treatment centers, and mass vaccination sites, where access to advanced medical facilities may be limited. Hence, the COVID-19 pandemic positively impacted the market.
However, the initial investment required for procuring these devices can be substantial, posing a barrier to adoption for healthcare organizations operating under tight budget constraints. Furthermore, beyond initial procurement and training, ongoing maintenance and replacement of consumables constitute recurring expenses associated with these devices. Hence, these aspects can lead to a downturn in the market.
By Devices Type Analysis
Based on devices type, the market is segmented into manual IO needles, battery powered driver, and impact driven devices. In 2023, the battery powered driver segment garnered a 26% revenue share in the market. Battery-powered drivers represent a significant advancement in intraosseous infusion technology, offering automated and motorized mechanisms for rapid and controlled insertion of intraosseous needles into the bone marrow space. These devices utilize battery-powered motors and mechanisms to drive the needle into the bone with consistent force and precision, minimizing user variability and enhancing procedural efficiency.
By End User Analysis
On the basis of end-use, the market is divided into hospitals & clinics, ambulatory surgical centers, and others. In 2023, the ambulatory surgical centers segment witnessed a 28% revenue share in the market. Ambulatory surgical centers have emerged as popular alternatives to traditional hospital-based care for various surgical procedures, including minor surgeries, diagnostic and therapeutic interventions, and emergency procedures. The convenience, efficiency, and cost-effectiveness of ASCs make them attractive options for patients seeking same-day procedures or short-stay surgical care.
By Regional Analysis
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured 40% revenue share in the market in 2023. North America, particularly the United States, faces a high burden of traumatic injuries, emergencies, and acute medical conditions, driving the demand for rapid and reliable vascular access solutions. These devices offer a valuable alternative for obtaining vascular access in critically ill or injured patients when traditional venous access is challenging or unattainable.
List of Key Companies Profiled
Aero Healthcare AU Pty Ltd
Teleflex Incorporated
Becton, Dickinson and Company
BIOPSYBELL S.R.L.
Cook Medical, Inc.(Cook Group)
The Seaberg Company Inc. (SAM Medical)
Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
Medax Srl
PAVmed Inc.
Global Intraosseous Infusion Devices Market Report Segmentation
By Devices Type
Manual IO Needles
Battery Powered Driver
Impact Driven Devices
By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Others
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Table of Contents
Chapter 1.Market Scope & Methodology
1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
1.4.1Global Intraosseous Infusion Devices Market, by Devices Type
1.4.2Global Intraosseous Infusion Devices Market, by End User
1.4.3Global Intraosseous Infusion Devices Market, by Geography
1.5Methodology for the research
Chapter 2.Market at a Glance
2.1Key Highlights
Chapter 3.Market Overview
3.1Introduction
3.1.1Overview
3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
3.2.1Market Drivers
3.2.2Market Restraints
3.2.3Market Opportunities
3.2.4Market Challenges
3.3Porter Five Forces Analysis
Chapter 4.Global Intraosseous Infusion Devices Market by Devices Type
4.1Global Manual IO Needles Market by Region
4.2Global Battery Powered Driver Market by Region
4.3Global Impact Driven Devices Market by Region
Chapter 5.Global Intraosseous Infusion Devices Market by End User
5.1Global Hospitals & Clinics Market by Region
5.2Global Ambulatory Surgical Centers Market by Region
5.3Global Others Market by Region
Chapter 6.Global Intraosseous Infusion Devices Market by Region
6.1North America Intraosseous Infusion Devices Market
6.1.1North America Intraosseous Infusion Devices Market by Devices Type
6.1.1.1North America Manual IO Needles Market by Country
6.1.1.2North America Battery Powered Driver Market by Country
6.1.1.3North America Impact Driven Devices Market by Country
6.1.2North America Intraosseous Infusion Devices Market by End User
6.1.2.1North America Hospitals & Clinics Market by Country
6.1.2.2North America Ambulatory Surgical Centers Market by Country
6.1.2.3North America Others Market by Country
6.1.3North America Intraosseous Infusion Devices Market by Country
6.1.3.1US Intraosseous Infusion Devices Market
6.1.3.1.1US Intraosseous Infusion Devices Market by Devices Type
6.1.3.1.2US Intraosseous Infusion Devices Market by End User
